SWOG clinical trial number
SWOG-8788

Phase III Evaluation of "High Dose" versus "Standard Dose" Cisplatin Combined with Bleomycin and VP-16 for Advanced Metastatic Testicular Cancer

Closed
Phase
Published
Abbreviated Title
Phase III Evaluation of "High Dose" versus "Standard Dose" Cisplatin Combined with Bleomycin and VP-16 for Advanced Metastatic Testicular Cancer
Activated
01/15/1988
Closed
09/15/1989

Publication Information Expand/Collapse

1991

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol.

CR Nichols;SD Williams;PJ Loehrer;FA Greco;ED Crawford;J Wettlaufer;ME Miller;A Bartolucci;L Schacter;LH Einhorn JCO 9(7):1163-1172

1990

Phase III study of cisplatin dose intensity in advanced germ cell tumors (GCT). A Southeastern and Southwest Oncology Group protocol.

L Einhorn;S Williams;P Loehrer;D Crawford;J Wettlaufer;A Bartolucci;L Schacter ASCO 9:132(#510)